An in vivo AAV–Sleeping Beauty-CRISPR screen targeting membrane proteins in CD8+ T cells in mouse models of GBM revealed that CAR-T cells with Pdia3 ablation possess enhanced killing ability. Here, CD8A is linked to glioblastoma.